蛋白質工程市場：按產品類型、按技術、按最終用戶、按地區

2025 年全球蛋白質工程市場規模估計為 42.1 億美元，預計到 2032 年將達到 122.6 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 16.5%。

圖。

蛋白質工程是透過合理或進化設計開發有用蛋白質的過程。定點突變、嵌合體建構和隨機誘變等技術用於開發所需的蛋白質結構和功能。全球蛋白質工程市場提供了龐大的機會，因為它能夠實現生物製藥、工業酵素、食品和飲料以及學術等產業的下游應用。該領域的主要目標蛋白質包括抗體、荷爾蒙和疫苗。基因合成、計算工具和結構生物學的進步正在加速這一領域的研究。

市場動態

全球蛋白質工程市場主要受到生物製藥行業的成長、合成生物學研究活動的增加以及基因合成等創新技術的出現等因素的推動。生物製藥公司正在積極利用定向進化和計算設計等技術來開發治療性抗體、酵素和蛋白質。然而，蛋白質工程技術高成本、合成生物學倫理問題等因素對市場構成了挑戰。蛋白質療法的不斷成長以及學術界和工業參與企業之間的合作為市場擴張提供了新的機會。

研究的主要特點

• 本研究報告對全球蛋白質工程市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 全球蛋白質工程市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過全球蛋白質工程市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第 4 章。

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020-2032 年全球蛋白質工程市場（按產品類型分類）（十億美元）

• 介紹
• 改良酵素
• 胰島素
• 單株抗體
• 凝血因子（血液因子+組織胞漿素原）
• 疫苗
• 生長因子（激素+細胞激素）
• 其他

6. 2020 年至 2032 年全球蛋白質工程市場（按技術分類）（十億美元）

• 介紹
• 非理性蛋白質設計
• 合理蛋白質設計

7. 2020-2032 年全球蛋白質工程市場（按最終用戶分類）（十億美元）

• 介紹
• 製藥和生物技術公司
• 合約研究組織 (CRO)
• 學術機構
• 其他

8. 2020 年至 2032 年全球蛋白質工程市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Agilent Technologies Inc.
  • Amgen Inc.
  • Bruker Corporation
  • Bio-Rad Laboratories Inc.
  • Eli Lilly and Company
  • Merck KGaA
  • Novo Nordisk AS
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • GenScript BIoTech Corporation
  • GE Healthcare
  • Absci
  • ElevateBio
  • Ingenza
  • Anima BIoTech
  • Ventus Therapeutics
  • Aether Biomachines, Inc.

第 10 章分析師建議

• 興衰
• 一致的機會地圖

第 11 章 參考文獻與調查方法

• 參考
• 調查方法

Global Protein Engineering Market is estimated to be valued at USD 4.21 Bn in 2025 and is expected to reach USD 12.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032.

Figure. Protein Engineering Market Share (%), By Region 2025

Protein engineering is the process of developing useful proteins through rational or evolutionary design. It employs techniques, such as site-directed mutagenesis, chimeric construction, and random mutagenesis, to develop desired protein structures and functions. The global protein engineering market offers significant opportunities as it enables downstream applications in industries including biopharmaceuticals, industrial enzymes, food and beverages, and academics. Major proteins targeted in this field include antibodies, hormones, and vaccines. Advancements in gene synthesis, computational tools, and structural biology have accelerated research in this field.

Market Dynamics:

The global protein engineering market is primarily driven by factors such as the growth of the biopharmaceutical industry, increasing research activities in synthetic biology, and advent of innovative technologies like gene synthesis. Biopharmaceutical companies are actively utilizing techniques such as directed evolution and computational design to develop therapeutic antibodies, enzymes, and proteins. However, factors such as high costs associated with protein engineering techniques and ethical issues pertaining to synthetic biology pose challenges to the market. Growing protein therapeutics pipeline and collaborations between academic and industrial players present new opportunities for market expansion.

Key Features of the Study:

• This report provides an in-depth analysis of the global protein engineering market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global protein engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, and Bruker Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global protein engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein engineering market.

Detailed Segmentation-

• By Product Type
  • Modified Enzymes
  • Insulin
  • Monoclonal Antibodies
  • Coagulation Factors (Blood Factors + Tissue Plasminogen)
  • Vaccines
  • Growth Factors (Hormones + Cytokine)
  • Other Product Types
• By Technology
  • Irrational Protein Design
  • Rational Protein Design
• By End User
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Academic Institutions
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Agilent Technologies Inc.
  • Amgen Inc.
  • Bruker Corporation
  • Bio-Rad Laboratories Inc.
  • Eli Lilly and Company
  • Merck KGaA
  • Novo Nordisk AS
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • GenScript Biotech Corporation
  • GE Healthcare
  • Absci
  • ElevateBio
  • Ingenza
  • Anima Biotech
  • Ventus Therapeutics
  • Aether Biomachines, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Protein Engineering Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Protein Engineering Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Modified Enzymes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Insulin
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Monoclonal Antibodies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Coagulation Factors (Blood Factors + Tissue Plasminogen)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Growth Factors (Hormones + Cytokine)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Product Types
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Protein Engineering Market, By Technology, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Irrational Protein Design
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rational Protein Design
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Protein Engineering Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CRO)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic Institutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Protein Engineering Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bruker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novo Nordisk AS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • GenScript Biotech Corporation
  • GE Healthcare
  • Absci
  • ElevateBio
  • Ingenza
  • Anima Biotech
  • Ventus Therapeutics
  • Aether Biomachines, Inc.

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact